Company Info
Phone(650) 473-7700
Year Established
1992
Ticker
GERN
Exchange
NASDAQ
Contacts
Anil KapurCCO
Andrew J. Grethlein, Ph.D.
COO
Edward Koval
CBO
Faye Feller, M.D.
CMO
John A. Scarlett, M.D.
Chair, President & CEO
Michelle Robertson
CFO
Stephen N. Rosenfield, J.D.
CLO
Lorraine Shui, Pharm.D., M.B.A
VP, Marketing
Scott Hutson
VP, Sales
Company Description
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.